Published in Medical Letter on the CDC and FDA, April 12th, 2009
“We are incredibly pleased to welcome Jack to our team,” says D. Lansing Taylor, Ph.D., CEO of Cellumen. “He is highly regarded for his work in early safety testing, and we are confident that he will serve as a trusted advisor for the team at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA